Oxford Nanopore Technologies 

€9.17
108
-€0.06-0.65% 08:55 今天

统计

当日最高
9.19
当日最低
9.17
52周高点
9.25
52周低点
7.45
成交量
-
平均成交量
-
市值
8.94B
市盈率
-
股息率
-
股息
-

即将到来

财报

8月19日预期
Q2 2026
-0.08
-0.07
-0.06
-0.06
预期EPS
-0.07604558935450201
实际EPS
-0.055642837194

财务

-64.87%利润率
未盈利
2020
2021
2022
2023
2024
2025
258.61M营收
-167.77M净利润

其他人也在关注

此列表基于在 Stock Events 上关注 4R00.F 的用户自选生成。这不是投资建议。

竞争对手

此列表为基于近期市场事件的分析。并非投资建议。

关于

Oxford Nanopore Technologies plc, founded in 2005 and originally known as Oxford NanoLabs Limited before its name change in May 2008, is a United Kingdom-based enterprise that specializes in developing and commercializing an innovative system for analyzing diverse molecular structures through nanopore-based sensing. Its product range features a variety of devices, including the portable MinION for sequencing deoxyribonucleic acid and ribonucleic acid, and the MinION Mk1C, which integrates basecalling, data analysis, touchscreen controls, and wireless connectivity. For benchtop operations, the company offers the GridION, capable of running and analyzing up to five MinION or Flongle flow cells, as well as the GridION Mk1 nanopore sequencer. High-yield sequencing is made accessible with the PromethION 2 Solo and PromethION 2, while the PromethION 24 and PromethION 48 provide benchtop nanopore sequencers for multiple users to achieve multi-sample and multi-experiment results. Further complementing these devices are Flongle, an adapter for MinION or GridION units, and VolTRAX, a USB-powered tool designed to automate laboratory processes preceding nanopore sequencing. The company also provides a suite of software solutions: MinKNOW facilitates data acquisition, real-time analysis and feedback, local basecalling, and data streaming; specialized Basecalling tools pinpoint the identity and sequence of bases on DNA/RNA molecules; EPI2ME is a cloud-based platform for comprehensive, real-time analysis of nanopore data; and EPI2ME Labs offers bioinformatics support to help users refine their skills and confidence in analyzing their sequencing data. Additionally, Oxford Nanopore Technologies is actively developing new products such as MinION Mk1D, Ubi, Plongle, and SmidgION. All of its products are available for purchase online.
显示更多
首席执行官
Francis Albert Luc Van Parys
员工
1314
国家
英国
ISIN
US69166E1047
WKN
000A3DZUG

上市

0 条评论

分享你的想法

常见问题

Oxford Nanopore Technologies 今天的股价是多少?▼
4R00.F 当前价格为 €9.17 EUR,在过去 24 小时内下跌了 -0.65%。在图表上更密切关注 Oxford Nanopore Technologies 股票的表现。
Oxford Nanopore Technologies 的股票代码是什么?▼
根据交易所不同,股票代码可能会有所不同。例如,在 Frankfurt Exchange 交易所,Oxford Nanopore Technologies 的股票以代码 4R00.F 进行交易。
Oxford Nanopore Technologies 的市值是多少?▼
今天 Oxford Nanopore Technologies 的市值为 8.94B
Oxford Nanopore Technologies 下一次财报日期是什么时候?▼
Oxford Nanopore Technologies 将于 2027年3月9日 发布下一次财报。
Oxford Nanopore Technologies 上一季度的财报怎么样?▼
4R00.F 上季度财报为每股 -0.06 EUR,预估为 -0.08 EUR,带来 +26.83% 的意外。下季度预估财报为每股 不适用 EUR。
Oxford Nanopore Technologies 去年的营收是多少?▼
Oxford Nanopore Technologies 去年的营收为 258.61MEUR。
Oxford Nanopore Technologies 去年的净利润是多少?▼
4R00.F 去年的净收益为 -167.77MEUR。
Oxford Nanopore Technologies 有多少名员工?▼
截至2026年11月2日,公司共有1,314名员工。
Oxford Nanopore Technologies 属于哪个行业?▼
Oxford Nanopore Technologies从事于健康与养生行业。
Oxford Nanopore Technologies 何时完成拆股?▼
Oxford Nanopore Technologies 最近没有进行任何拆股。
Oxford Nanopore Technologies 的总部在哪里?▼
Oxford Nanopore Technologies 的总部位于 英国 的 Oxford。